OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

TechCrunch · 2 min read · business

Read original article →

OpenAI researcher Miles Wang is launching an AI drug discovery startup, raising approximately $200 million at a $2 billion valuation with Lightspeed leading discussions. Wang co-authored OpenAI research on accelerating scientific discovery using AI.